Krzysztof Simon
- Hepatology top 0.2%
- Hepatitis C virus research 60
- Hepatitis Viruses Studies and Epidemiology 9
- Hepatocellular Carcinoma Treatment and Prognosis 8
- Epidemiology top 0.5%
- Liver Disease Diagnosis and Treatment 71
- Hepatitis B Virus Studies 61
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies 26
- SARS-CoV-2 and COVID-19 Research 13
- Neurology top 5%
- Long-Term Effects of COVID-19 17
- Health top 10%
- Co-authors
- Harry L.A. JanssenBettina E. HansenYılmaz ÇakaloğluUlus Salih AkarcaStefan ZeuzemHakan ŞentürkRobert FlisiakRobert A. de Man
- Journals
- The Lancet (2 papers)Journal of Clinical Oncology (2 papers)SHILAP Revista de lepidopterología (5 papers)
- Partner nations
- PolandUnited StatesTürkiye
In The Last Decade
Krzysztof Simon
177 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Hepatology 2.4k
- Epidemiology 2.6k
- Infectious Diseases 580
- Neurology 195
- Health 98
Countries citing papers authored by Krzysztof Simon
This map shows the geographic impact of Krzysztof Simon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krzysztof Simon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krzysztof Simon more than expected).
Fields of papers citing papers by Krzysztof Simon
This network shows the impact of papers produced by Krzysztof Simon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krzysztof Simon. The network helps show where Krzysztof Simon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Krzysztof Simon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 10 | |
| 8 | 2022 | 1 | |
| 9 | 2021 | 6 | |
| 10 | 2021 | 20 | |
| 11 | 2021 | 21 | |
| 12 | 2021 | 95 | |
| 13 | 2020 | 12 | |
| 14 | Recommendations for elastography-based imaging of liver. | 2015 | 3 |
| 15 | 2015 | 7 | |
| 16 | 2013 | 8 | |
| 17 | [Therapeutic recommendations for year 2010: antiviral treatment of chronic HBV infection]. | 2010 | 1 |
| 18 | 2009 | 36 | |
| 19 | 2008 | 300 | |
| 20 | [Fluorescence of age in serum in detecting liver cirrhosis and hepatocellular carcinoma among patients with anti-HCV antibodies]. | 2008 | 4 |
About Krzysztof Simon
Krzysztof Simon is a scholar working on Hepatology, Epidemiology and Infectious Diseases, having authored 193 papers that have together received 3.7k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (71 papers), Hepatitis B Virus Studies (61 papers), Hepatitis C virus research (60 papers), COVID-19 Clinical Research Studies (26 papers), Long-Term Effects of COVID-19 (17 papers), SARS-CoV-2 and COVID-19 Research (13 papers), Hepatitis Viruses Studies and Epidemiology (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (8 papers). The work is most often cited by research in Hepatology (2.4k citations), Epidemiology (2.6k citations) and Infectious Diseases (580 citations). Krzysztof Simon has collaborated with scholars based in Poland, United States and Türkiye. Frequent co-authors include Harry L.A. Janssen, Bettina E. Hansen, Yılmaz Çakaloğlu, Ulus Salih Akarca, Stefan Zeuzem, Hakan Şentürk, Robert Flisiak, Robert A. de Man, Solko W. Schalm and Monika van Zonneveld. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.